NCT06863051 Effect of Albumin Platelet-Rich Fibrin or Leucocyte- Platelet-Rich Fibrin on Immediate Implant
| NCT ID | NCT06863051 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kafrelsheikh University |
| Condition | Immediate Implant Placement |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-08-20 |
| Primary Completion | 2026-02-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-08-20 with a primary completion date of 2026-02-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study will be to compare between Immediate Implant grafted with xenograft and Alb-PRF gel versus xenograft with L-PRF.
Eligibility Criteria
1. Inclusion criteria * The presence of non-restorable mandibular molar. * Patient 18-45 years old * Intact buccal and lingual walls * Good oral hygiene. * Prescence of sufficient restorative space. * Jumping gap more than 2 mm. 2. Exclusion criteria * Proximity of anatomical structures * Acute localized infection (suppuration at the surgical field) * Patients on chemotherapy or radiotherapy. * Patients who have systemic disorders (diseases) {diabetes mellitus, autoimmune disease, …etc}, * Pregnant patients. * Smoking and Alcohols. * Presence of periapical pathology affecting the neighboring teeth.
Contact & Investigator
Mostafa Mohamed Fayed, Demonstrator of Periodontology
✉ mostafa.mohamed@den.kfs.edu.eg📞 0201004668099
Frequently Asked Questions
Who can join the NCT06863051 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Immediate Implant Placement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06863051 currently recruiting?
Yes, NCT06863051 is actively recruiting participants. Contact the research team at mostafa.mohamed@den.kfs.edu.eg for enrollment information.
Where is the NCT06863051 trial being conducted?
This trial is being conducted at Kafr ash Shaykh, Egypt.
Who is sponsoring the NCT06863051 clinical trial?
NCT06863051 is sponsored by Kafrelsheikh University. The trial plans to enroll 20 participants.